Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies

NCT02182245 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Genital Neoplasms, Female

Interventions

DRUG: BIBF 1120
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Boehringer Ingelheim